Design of histidine-rich peptides with enhanced bioavailability and inhibitory activity against hepatitis C virus

Recently, peptide drugs have evolved into mainstream therapeutics, representing a significant portion of the pharmaceutical market. However, their bioavailability remains to be improved compared with that of chemical drugs. Here, we screened and identified a new peptide, Ctry2459, from a scorpion ve...

Descripción completa

Detalles Bibliográficos
Autores principales: Hong, Wei, Zhang, Runhong, Di, Zhiyong, He, Yawen, Zhao, Zhenhuan, Hu, Jun, Wu, Yingliang, Li, Wenxin, Cao, Zhijian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2013
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7124613/
https://www.ncbi.nlm.nih.gov/pubmed/23415044
http://dx.doi.org/10.1016/j.biomaterials.2013.01.075

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7124613/
https://www.ncbi.nlm.nih.gov/pubmed/23415044
http://dx.doi.org/10.1016/j.biomaterials.2013.01.075

Ejemplares similares